| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.35 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |